---
title: Scientific Flagship Projects
permalink: /scientific-flagship-projects/
variant: tiptap
description: Scientific Flagship Projects
third_nav_title: PRECISE SG100K data resource
---
<p>PRECISE-SG100K initiated an open Call for Proposals in November 2023 inviting
researchers in Singapore to submit proposals that utilise the rich PRECISE-SG100K
resource and aim to advance scientific knowledge and enable clinical translation.</p>
<p>The PRECISE-SG100K Scientific Committee went through a rigorous evaluation
process to select <strong>eight Flagship Projects </strong>based on their
alignment to the research strategy of the National Precision Medicine programme
and their potential to generate insightful and impactful observations.</p>
<p>These Flagship Projects will be showcased as key research outcomes of
the National Precision Medicine programme and will work closely with the
PRECISE-SG100K Scientific Committee and Data Science Team to establish
Singapore as a leader in the field of Precision Medicine.</p>
<p>Additionally, 28 <a href="/scientific-driver-projects/" rel="noopener noreferrer nofollow" target="_blank">Driver Projects</a> were also selected
based on the scientific value, deliverables, project plan, and project
team.</p>
<p></p>
<table style="minWidth: 125px">
<colgroup>
<col>
<col>
<col>
<col>
<col>
</colgroup>
<tbody>
<tr>
<td rowspan="1" colspan="1">
<p><strong>S/N</strong>
</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Flagship Project Title</strong>
</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Team</strong>
</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Aims of Project</strong>
</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Institutions Involved</strong>
</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>1</p>
</td>
<td rowspan="1" colspan="1">
<p>The SG100K cognitive health programme</p>
<p></p>
<p>Topic: Mental Health</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Dr Max Lam, Lee Kong Chian School of Medicine,
Institute of Mental Health</p>
<p><strong>Co-Lead PI:</strong> Dr Jimmy Lee, Institute of Mental Health</p>
<p><strong>Co-Lead PI:</strong> Prof Liu Jianjun, Acting Executive Director,
Genome Institute of Singapore</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Establish the biological underpinnings
for cognitive function in diverse Asian and global populations,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Establish the biological convergence
between cognitive function and disease traits, and</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Establish epidemiological and genomic
risk predictors of cognitive health.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lee Kong Chian School of Medicine</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nanyang Technological University</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Institute of Mental Health</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Neuroscience Institute</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Genome Institute of Singapore</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>2</p>
</td>
<td rowspan="1" colspan="1">
<p>The SG100K_Med Alliance - clinical genetics researchers united for the
analysis of mendelian disease variation in SG100K</p>
<p></p>
<p>Topic: Mendelian Diseases</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Dr Lim Weng Khong, Duke-NUS Medical School</p>
<p><strong>Co-Lead PI:</strong> Dr Joanne Ngeow, Lee Kong Chian School of
Medicine</p>
<p><strong>Co-Lead PI:</strong> Dr Saumya Jamuar, KK Women's and Children's
Hospital</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seek a deeper understanding of
genetic disease burden in major Asian populations through a comprehensive
analysis of structural variation and short tandem repeat expansions,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Demonstrate how SG100K data can
resolve variants of uncertain significance, and</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Explore impact of polygenic backgrounds
on penetrance in autosomal dominant conditions for under-represented Asian
populations.</p>
<p><strong>&nbsp;</strong>
</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duke-NUS Medical School</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lee Kong Chian School of Medicine</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; KK Women's and Children's Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Genome Institute of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Singapore National Eye Centre</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tan Tock Seng Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Heart Centre Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Neuroscience Institute</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Khoo Teck Puat Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nanyang Technological University</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>3</p>
</td>
<td rowspan="1" colspan="1">
<p>Identification of Asian-specific genetic association with fat and lean
muscle mass distribution</p>
<p></p>
<p>Topic: Fat and Lean Muscle Mass</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Dr Liu Boxiang, National University of Singapore</p>
<p><strong>Co-Lead PI: </strong>A/P Sim Xueling, National University of Singapore</p>
<p><strong>Co-Lead PI:</strong> Prof Tai E Shyong, National University of
Singapore</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perform multi-ethnic meta-analysis
of fat and lean muscle mass using SG100K and UKBB datasets,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mendelian randomisation analysis
to identify the contribution of fat and lean muscle mass to cardiometabolic
diseases,</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colocalisation analysis to identify
risk genes affecting fat and lean muscle mass, and</p>
<p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conduct functional validation studies
of identified genetic loci.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University of Singapore</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>4</p>
</td>
<td rowspan="1" colspan="1">
<p>HLA alleles and its association with auto-immune diseases and pharmacogenomics
in multi-ancestral Asian populations</p>
<p></p>
<p>Topic: Human Leukocyte Antigen</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> A/P Sim Xueling, National University of Singapore</p>
<p><strong>Co-Lead PI:</strong> Dr Leong Khai Pang, Tan Tock Seng Hospital</p>
<p><strong>Co-Lead PI:</strong> Dr Wharton Chan, Duke-NUS Medical School</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate a high-resolution human
leukocyte antigen (HLA) reference panel in Asian populations,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate frequencies of HLA alleles
and haplotypes in Asian populations for local reference and for global
population comparisons, and</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conduct association analyses of
HLA alleles in outcomes including auto-immune diseases and pharmacogenomic
responses.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tan Tock Seng Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duke-NUS Medical School</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>5</p>
</td>
<td rowspan="1" colspan="1">
<p>Unravelling the determinants of kidney health in a multi-ethnic Asian
population</p>
<p></p>
<p>Topic: Kidney Disease</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Dr Yeo See Cheng, Tan Tock Seng Hospital</p>
<p><strong>Co-Lead PI:</strong> Prof John Chambers, Lee Kong Chian School
of Medicine</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Determine prevalence of chronic
kidney disease (CKD) among adults</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Examine association of CKD with
genetic, clinical and socio-behavioural predictors,</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Examine relative contribution of
key predictors driving differences in CKD risks across different sub-population,
and</p>
<p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Develop and validate an integrated
risk score for the development of CKD in a representative multi-ethnic
Asian population-based cohort in Singapore.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tan Tock Seng Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lee Kong Chian School of Medicine</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>6</p>
</td>
<td rowspan="1" colspan="1">
<p>The high variability of tandem repeats offers insights into population
diversity and may explain the missing heritability of complex neurological
and neurocognitive disorders in Asian populations</p>
<p></p>
<p>Topic: Tandem Repeats</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Prof Liu Jianjun, A*STAR Genome Institute of
Singapore</p>
<p><strong>Co-Lead PI:</strong> Dr Nicolas Bertin, A*STAR Genome Institute
of Singapore</p>
<p><strong>Co-Lead PI:</strong> Dr Lim Weng Khong, Duke-NUS Medical School</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate SG100K genome wide tandem
repeats (TR) variation catalogue and characterisation their respective
prevalence in Asian populations, and</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Characterise contributions of TR
variations to the aetiology of complex neurological and neurocognitive
disorders.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Genome Institute of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duke-NUS Medical School</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Neuroscience Institute</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>7</p>
</td>
<td rowspan="1" colspan="1">
<p>An integrated pharmacoeconomic-pharmacokinetic framework for prioritising
and testing clinically important drug-gene interactions</p>
<p></p>
<p>Topic: Pharmacogenomics</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Dr Janice Goh, A*STAR Bioinformatics Institute</p>
<p><strong>Co-Lead PI:</strong> A/P Wee Hwee Lin, National University of Singapore</p>
<p><strong>Co-Lead PI:</strong> Dr Nicolas Bertin, A*STAR Genome Institute
of Singapore</p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluate the occurrence of known
drug-gene interactions based on EHR data and its impact on efficacy and
toxicity,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Explore genotype-drug response
associations using SG100K and linked EHR datasets augmented by a dedicated
pipeline for haplotyping highly polymorphic drug metabolising enzyme CYP2D6,
and</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Develop a pharmacokinetics-informed
framework for evaluating and ranking both known and novel drug-gene sets
for clinical action to make dose recommendations</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Bioinformatics Institute</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Genome Institute of Singapore</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>8</p>
</td>
<td rowspan="1" colspan="1">
<p>Genetic variants contributing to clonal haematopoiesis across diverse
Asian genomes</p>
<p></p>
<p>Topic: Clonal Hermatopoiesis</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Lead PI:</strong> Prof Ong Sin Tiong, Duke-NUS Medical School</p>
<p><strong>Co-Lead PI:</strong> Prof Ashok Venkitaraman, National University
of Singapore</p>
<p><strong>Co-Lead PI:</strong> Prof Chng Wee Joo, National University of
Singapore</p>
<p><strong>Co-Lead PI:</strong> Prof John Chambers, Lee Kong Chian School
of Medicine</p>
<p><strong>Co-Lead PI:</strong> Dr Nicolas Bertin, A*STAR Genome Institute
of Singapore</p>
<p></p>
</td>
<td rowspan="1" colspan="1">
<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Determine age-related incidence
of clonal haematopoiesis (CH) among our three major ancestry groups,</p>
<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Correlate CH status with clinical
metadata, measures of ageing and disease incidence, and disease-related
variables including biomarkers,</p>
<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discover novel genetic associations
with CH,</p>
<p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Integrate functional genomics for
novel Asian CH driver mutation discovery and validation, and</p>
<p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Correlate CH status with cell clusters
and gene expression signatures in the AIDA scRNA-seq dataset.</p>
</td>
<td rowspan="1" colspan="1">
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Duke-NUS Medical School</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lee Kong Chian School of Medicine</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A*STAR Genome Institute of Singapore</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National University Hospital</p>
<p>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Singapore General Hospital</p>
</td>
</tr>
</tbody>
</table>
<p></p>
<p></p>